iNKT cell therapy

invariant natural killer T cell adoptive transfer · Beijing YouAn Hospital

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for iNKT cell therapy, covering 2024-10-08 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: Nogapendekin Alfa-Inbakicept and iNKT Cells for Critically Ill Adults With Severe Community-Acquired Pneumonia (With or Without Sepsis/ARDS) [Phase 2]

See pricing